TokenPost·
Hemab Records $0.58 Loss Per Share in Third Quarter of 2026
Net loss rose to $27.3 million from $17.1 million a year earlier as operating and research expenses increased.
More news
- TokenPostZKsync Launches Prividium Connect for Institutional Cross-Chain Trades
- TokenPostGram (Prev. Toncoin) Rose 8.31% in Four Hours to $1.24
- TokenPostAlibaba Says 平头哥 Filed Confidentially for Hong Kong Listing
- TokenPostAnsem Promotes mihao as Token Briefly Jumps 50% and Tops $17M
- Crypto BriefingBinance pledges legal support for female employees targeted by smear campaigns
- TokenPostPoesis Plans to Open AI Clarity to Outside Clients in Early 2027